Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
IL-15 regulates memory CD8+ T cell O-glycan synthesis and affects trafficking
Jeffrey C. Nolz, John T. Harty
Jeffrey C. Nolz, John T. Harty
Published February 10, 2014
Citation Information: J Clin Invest. 2014;124(3):1013-1026. https://doi.org/10.1172/JCI72039.
View: Text | PDF
Research Article Immunology

IL-15 regulates memory CD8+ T cell O-glycan synthesis and affects trafficking

  • Text
  • PDF
Abstract

Memory and naive CD8+ T cells exhibit distinct trafficking patterns. Specifically, memory but not naive CD8+ T cells are recruited to inflamed tissues in an antigen-independent manner. However, the molecular mechanisms that regulate memory CD8+ T cell trafficking are largely unknown. Here, using murine models of infection and T cell transfer, we found that memory but not naive CD8+ T cells dynamically regulate expression of core 2 O-glycans, which interact with P- and E-selectins to modulate trafficking to inflamed tissues. Following infection, antigen-specific effector CD8+ T cells strongly expressed core 2 O-glycans, but this glycosylation pattern was lost by most memory CD8+ T cells. After unrelated infection or inflammatory challenge, memory CD8+ T cells synthesized core 2 O-glycans independently of antigen restimulation. The presence of core 2 O-glycans subsequently directed these cells to inflamed tissue. Memory and naive CD8+ T cells exhibited the opposite pattern of epigenetic modifications at the Gcnt1 locus, which encodes the enzyme that initiates core 2 O-glycan synthesis. The open chromatin configuration in memory CD8+ T cells permitted de novo generation of core 2 O-glycans in a TCR-independent, but IL-15–dependent, manner. Thus, IL-15 stimulation promotes antigen-experienced memory CD8+ T cells to generate core 2 O-glycans, which subsequently localize them to inflamed tissues. These findings suggest that CD8+ memory T cell trafficking potentially can be manipulated to improve host defense and immunotherapy.

Authors

Jeffrey C. Nolz, John T. Harty

×

Figure 8

Regulation of Gcnt1 expression in antigen-specific CD8+ T cells following infection.

Options: View larger image (or click on image) Download as PowerPoint
Regulation of Gcnt1 expression in antigen-specific CD8+ T cells followin...
(A) The core 1 O-glycan structure originating from a serine or threonine amino acid (S/T) is formed by the addition of galactose in a β1-3 linkage to N-acetylgalactosamine. Generation of the core 2 structure occurs following activity of one of three core 2 β1,6-N-acetylglucosaminyltransferases (C2GlcNAcT) on the core 1 structure. Subsequent activity by other glycotransferases ultimately results in core 2 O-glycan extension and generation of the sialyl Lewis X. (B) Core 1 O-glycan expression (binding of the lectin jacalin) of P14 CD8+ T cells following LCMV infection. (C) Quantification of Gcnt1, Gcnt3, and Gcnt4 mRNA in naive, effector (day 5 after infection), and memory (day 75 after infection) P14 CD8+ T cells following LCMV infection. Changes in gene expression were determined using Hprt as a reference gene. (D) Naive, effector, and memory P14 CD8+ T cells were purified, and Gcnt1 expression was determined by immunoblot. (E) Using transcript variant-specific 5′ primers, only expression of Gcnt1 transcript variant 1 could be detected in antigen-specific CD8+ T cells following LCMV infection. (F) Enrichment of trimethylated lysine 27 (H3K27me3) and trimethylated lysine 4 (H3K4me3) histone H3 modifications at the Gcnt1 promoter region in naive and memory CD8+ T cell populations. Values on the x axis indicate the median position of the amplified region of DNA relative to the transcription start site of Gcnt1 variant 1. Data are representative of 2 or more independent experiments.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts